Bester Clara, Käsbohrer Annemarie, Wilkins Neil, Correia Carreira Guido, Marschik Tatiana
Centre for Food Science and Veterinary Public Health, Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine, Vienna, Austria.
Unit Epidemiology, Zoonoses and Antimicrobial Resistance, Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Front Vet Sci. 2024 Mar 18;11:1380029. doi: 10.3389/fvets.2024.1380029. eCollection 2024.
The continued occurrence of salmonellosis cases in Europe attributed to the consumption of pork products highlights the importance of identifying cost-effective interventions. Certain biosecurity measures (BSMs) may be effective in reducing the prevalence of specific pathogens along the pork production chain and their presence in food products. The objective of this study was to identify pathogen-specific, cost-effective BSMs to reduce Salmonella at different stages of the pork production chain in two European countries - Austria (AT) and the United Kingdom (UK). For this purpose, a cost-benefit analysis was conducted based on the epidemiological output of an established quantitative microbiological risk assessment that simulated the implementation effect of the BSMs based on their risk ratios. For each of the BSMs, the associated costs and benefits were assessed individually and country-specifically. For both AT and UK, nine different BSMs were evaluated assuming a countrywide implementation rate of 100%. The results showed that four BSMs were cost-effective (benefit-cost ratio > 1) for AT and five for the UK. The uncertainty regarding the cost-effectiveness of the BSMs resulted from the variability of individual risk ratios, and the variability of benefits associated with the implementation of the BSMs. The low number of cost-effective BSMs highlights the need for holistic risk-based models and economic assessments. To increase the willingness to implement BSMs and maximize the benefits for stakeholders, who carry the majority of the implementation costs, epidemiological assessments of BSM effectiveness should consider the impact on several relevant pathogens simultaneously.
欧洲因食用猪肉制品而持续出现沙门氏菌病病例,这凸显了确定具有成本效益的干预措施的重要性。某些生物安全措施(BSMs)可能有效地降低猪肉生产链中特定病原体的流行率及其在食品中的存在。本研究的目的是确定针对特定病原体的、具有成本效益的生物安全措施,以减少奥地利(AT)和英国(UK)这两个欧洲国家猪肉生产链不同阶段的沙门氏菌。为此,基于已建立的定量微生物风险评估的流行病学结果进行了成本效益分析,该评估根据风险比率模拟了生物安全措施的实施效果。对于每一项生物安全措施,分别并按国家评估了相关成本和效益。对于奥地利和英国,假设全国实施率为100%,评估了九种不同的生物安全措施。结果表明,奥地利有四项生物安全措施具有成本效益(效益成本比>1),英国有五项。生物安全措施成本效益的不确定性源于个体风险比率的变异性以及与生物安全措施实施相关的效益变异性。具有成本效益的生物安全措施数量较少,凸显了基于风险的整体模型和经济评估的必要性。为了提高实施生物安全措施的意愿并为承担大部分实施成本的利益相关者最大化效益,生物安全措施有效性的流行病学评估应同时考虑对几种相关病原体的影响。